文献速递糖尿病

ALDH2 rs671 与日本男性空腹血糖升高、葡萄糖清除率降低及肝脏胰岛素抵抗相关

ALDH2 rs671 Is Associated With Elevated FPG, Reduced Glucose Clearance and Hepatic Insulin Resistance in Japanese Men.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究纳入94名非肥胖、非糖尿病日本男性,采用两步高胰岛素-正葡萄糖钳夹评估肌肉和肝脏胰岛素敏感性,并按 ALDH2 rs671 基因型分为风险携带组(G/G,n=53)和非风险携带组(G/A 或 A/A,n=41)。结果显示风险携带组饮酒量更高、空腹血糖更高、肝脏胰岛素敏感性更低、空腹葡萄糖清除率更低,而肌肉胰岛素抵抗和体脂分布相似。结论提示 ALDH2 rs671 G/G 携带者的肝脏胰岛素抵抗和空腹葡萄糖清除率降低可能是相对上游的代谢异常。

要点

  • ALDH2 rs671 G/G 携带者空腹血糖更高且肝脏胰岛素敏感性更低。
  • 风险携带组空腹葡萄糖清除率降低,但肌肉胰岛素抵抗与体脂分布无差异。
  • 饮酒量与肝脏胰岛素敏感性、空腹葡萄糖清除率及空腹血糖相关。

核心结论

  • ALDH2 rs671 G/G 携带者存在饮酒依赖和非依赖的肝脏胰岛素抵抗,以及高饮酒导致的空腹葡萄糖清除率降低,可能是相对上游的代谢异常。

研究设计与样本

  • 研究纳入94名非肥胖、非糖尿病日本男性,使用两步高胰岛素-正葡萄糖钳夹评估肌肉和肝脏胰岛素敏感性。
  • 采用 1H-磁共振波谱和磁共振成像分别测量肝内脂质和脂肪分布。
  • 按 ALDH2 rs671 基因型分为风险携带组 G/G(n=53)和非风险携带组 G/A 或 A/A(n=41)。

主要发现

  • 风险携带组饮酒量显著高于非风险携带组:18.4(IQR 10.4-48.9)vs 12.1(IQR 1.3-29.0)g/day,P = .003。
  • 风险携带组空腹血糖显著升高:97.5 ± 7.9 vs 93.5 ± 6.2 mg/dL,P = .010。
  • 风险携带组肝脏胰岛素敏感性显著降低:61.7 ± 20.5% vs 73.1 ± 15.9%,P = .003。
  • 风险携带组空腹葡萄糖清除率显著降低:0.84 ± 0.8 dL·m-2·min-1 vs 0.87 ± 0.09 dL·m-2·min-1,P = .047。
  • 肌肉胰岛素抵抗和体脂分布两组相似;单线性相关分析显示饮酒量与肝脏胰岛素敏感性(r = -0.262,P = .011)、空腹葡萄糖清除率(r = -0.370,P < .001)和空腹血糖(r = 0.489,P < .001)显著相关。

关键数值与推荐

  • 多回归分析显示 ALDH2 rs671 G/G 基因型和饮酒量均为肝脏胰岛素敏感性的显著独立相关因素。
  • 多回归分析显示仅饮酒量为空腹葡萄糖清除率的显著独立相关因素。

临床怎么用

  • 对 ALDH2 rs671 G/G 男性携带者应关注空腹血糖和肝脏胰岛素抵抗,评估饮酒量并考虑减少饮酒以改善代谢风险。

局限性

  • 研究仅纳入非肥胖、非糖尿病日本男性,样本量94例,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: A recent meta-analysis of genome-wide association studies data from East Asians identified aldehyde dehydrogenase 2 (ALDH2) rs671 as a susceptibility variant for type 2 diabetes in males. OBJECTIVE: To investigate the association between ALDH2 rs671 and metabolic characteristics. METHODS: We studied 94 nonobese, nondiabetic, Japanese men. Using a 2-step hyperinsulinemic-euglycemic clamp, we evaluated insulin sensitivity in muscle and liver. Intrahepatic lipid and fat distribution were measured using 1H-magnetic resonance spectroscopy and magnetic resonance imaging, respectively. We divided participants into a risk-carrying group with ALDH2 rs671 G/G (n = 53) and a nonrisk-carrying group with ALDH2 rs671 G/A or A/A (n = 41). RESULTS: The risk-carrying group had significantly higher levels of alcohol consumption (18.4 [interquartile range, IQR, 10.4-48.9]) vs 12.1 (IQR, 1.3-29.0) g/day; P = .003), elevated fasting plasma glucose (FPG) (97.5 ± 7.9 vs 93.5 ± 6.2 mg/dL; P = .010), lower hepatic insulin sensitivity (61.7 ± 20.5% vs 73.1 ± 15.9%; P = .003), and lower fasting glucose clearance (0.84 ± 0.8 dL·m-2·min-1 vs 0.87 ± 0.09 dL·m-2·min-1; P = .047) than the nonrisk-carrying group, while insulin resistance in muscle and body fat distribution were similar. The single linear correlation analysis revealed significant correlations between alcohol consumption and hepatic insulin sensitivity (r = -0.262, P = .011), fasting glucose clearance (r = -0.370, P < .001), or FPG (r = 0.489, P < .001). The multiple regression analysis revealed that both ALDH2 rs671 G/G genotype and alcohol consumption were significant independent correlates for hepatic insulin sensitivity, whereas only alcohol consumption was a significant independent correlate for fasting glucose clearance. CONCLUSION: Our data suggest that high-alcohol intake-dependent and independent hepatic insulin resistance and reduced fasting glucose clearance due to high alcohol intake could be a relatively upstream metabolic abnormality in ALDH2 rs671 G/G carriers.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Takeno K, Tamura Y, Kakehi S, et al. ALDH2 rs671 Is Associated With Elevated FPG, Reduced Glucose Clearance and Hepatic Insulin Resistance in Japanese Men. J Clin Endocrinol Metab. 2021. PMID: 33974068. doi:10.1210/clinem/dgab324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。